Home
Structural Heart Disease

Structural Heart Disease

TIO 2023 – Atrioventricular Valve Replacement Beyond TEER?

Azeem Latib Kendra J Grubb Lars Søndergaard et al

1.00 EBAC

Published: 12/06/2023

Compare the utility of repair and replacement valve technology in mitral regurgitation
Individualise valve choice for aortic regurgitation based on valve durability and patient features
Recall the utility and limitations of specialty balloons
Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
Identify suitable patients for interatrial shunting
Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI

HCM in Review: Highlights of 2022

0.25 AMA PRA Credit

Published: 06/01/2023

Recall the efficacy and safety of existing HCM treatments
Summarise results from ongoing trials with experimental treatments

HCM in Review: Assessing SCD Risk in HCM & Managing HCM With High Risk SCD

Perry Elliott

0.50 AMA PRA Credit

Published: 18/11/2022

Recall risk factors associated with sudden cardiac death (SCD)
Recall best practice approaches to prevent SCD according to guidelines and expert insight
Stratify patients likely to benefit from invasive procedures versus pharmacological treatment

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Thomas Modine David Wood Victoria Delgado et al

1.00 EBAC

Published: 14/09/2022

Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
Summarise clinical evidence for TAVI in low surgical risk patients
Recall different guideline recommendations for SAVR and TAVI approaches
Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient

HCM in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies

Ahmad Masri

0.50 AMA PRA Credit

Published: 03/08/2022

Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities

Hypertrophic Cardiomyopathy in Review: Highlights of ACC 2022

HCM in Review: Highlights of ACC 2022

0.25 AMA PRA Credit

Published: 21/06/2022

Recall the efficacy and safety of existing HCM treatments
Summarise results from ongoing trials with experimental treatments

Structural Heart Disease

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Thomas Modine David Wood Victoria Delgado et al

1.00 EBAC

Published: 14/09/2022

Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
Summarise clinical evidence for TAVI in low surgical risk patients
Recall different guideline recommendations for SAVR and TAVI approaches
Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient

TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?

Darren Mylotte Francesca Sanguineti Verena Veulemans et al

1.00 EBAC

Published: 19/04/2024

Evaluate the factors influencing coronary access in different valve designs
Formulate strategies to optimise coronary access based on valve characteristics
Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
Learn the step-by-step process for achieving optimum implant depth during TAVI
Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures

Streamlining TAVI: Delivering the Best Patients Outcomes and Efficient Pathways

Mohamed Abdel-Wahab Christopher Malkin Kendra J Grubb

1.00 EBAC

Published: 13/07/2021

Discuss the patient management considerations for TAVI
Discuss resource utilization and examples that may improve procedure efficiencies
Review TAVI cases that highlight patient management and procedure efficiencies

TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately?

Philippe Genereux Philippe Pibarot Philip MacCarthy

1.00 EBAC

Published: 13/07/2021

Describe how echo-based and catheter-based measurements differ when measuring haemodynamics post-TAVI
Recall common factors impacting the accuracy of haemodynamic measurements and how they can be controlled
Evaluate the relationship between TAVI and clinical outcomes based on clinical data
Summarise how haemodynamic monitoring can be adopted post-TAVI

TIO 2021 – Coronary Heart Disease: Contemporary Insights in Imaging and Physiology

Ajay J Kirtane Margaret B McEntegart David Hildick-Smith

1.00 EBAC

Published: 10/12/2021

Discuss the expanding number of indications in TAVI
Select appropriate devices for specific patient groups
Recall advances in invasive imaging techniques to aid clinical decision making
Summarise the essential principles of mechanical circulatory support

TIO 2020 – Technologies and Controversies

Nicolas M Van Mieghem Ajay J Kirtane Holger Thiele

1.00 EBAC

Published: 16/10/2020

Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
Assess the merits of adopting emerging technologies within their practice
Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
Interact with opinion leaders in their profession

Structural Heart Disease

TIO 2021 – Live Cases and Discussion – Complex PCI with MCS & Wrap-up

Ajay J Kirtane Nicolas M Van Mieghem Holger Thiele et al

1.00 EBAC

Published: 20/12/2021

Discuss the expanding number of indications in TAVI
Select appropriate devices for specific patient groups
Recall advances in invasive imaging techniques to aid clinical decision making
Summarise the essential principles of mechanical circulatory support

Streamlining TAVI: Delivering the Best Patients Outcomes and Efficient Pathways

Mohamed Abdel-Wahab Christopher Malkin Kendra J Grubb

1.00 EBAC

Published: 13/07/2021

Discuss the patient management considerations for TAVI
Discuss resource utilization and examples that may improve procedure efficiencies
Review TAVI cases that highlight patient management and procedure efficiencies

TIO 2022 - Session 1.1: Next Level Structural Heart Interventions

Nicolas M Van Mieghem Lars Søndergaard Azeem Latib et al

1.00 EBAC

Published: 16/05/2022

Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
Discuss the need for gender-specific trials and renal denervation

Transcatheter Interventions Online: Structural Heart Interventions: TAVI Focus

TIO 2020 – TAVI Focus

Nicolas M Van Mieghem Roxana Mehran Azeem Latib

1.00 EBAC

Published: 22/10/2020

Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
Assess the merits of adopting emerging technologies within their practice
Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
Interact with opinion leaders in their profession

TIO 2022 - Session 3.4: Debates

Nicolas M Van Mieghem Ajay J Kirtane Holger Thiele et al

1.00 EBAC

Published: 20/05/2022

Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
Discuss the need for gender-specific trials and renal denervation

TIO 2020 – Trials

Roxana Mehran Holger Thiele Ajay J Kirtane

1.00 EBAC

Published: 16/10/2020

Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
Assess the merits of adopting emerging technologies within their practice
Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
Interact with opinion leaders in their profession

Structural Heart Disease

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Structural Heart Disease

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Structural Heart Disease

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives

Learning objectives